Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Freeport-McMoRan Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements related to safety practices at its Grasberg Block Cave mine in Indonesia [1][3]. Group 1: Allegations - The complaint alleges that Freeport-McMoRan did not adequately ensure safety at the Grasberg Block Cave mine, which heightened the risk of worker fatalities [3]. - It is claimed that the lack of proper safety precautions led to undisclosed regulatory, litigation, and reputational risks for the company [3]. - The statements made by the defendants regarding Freeport-McMoRan's business operations and prospects were materially false and misleading, lacking a reasonable basis during the class period [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as February 15, 2022, to September 24, 2025 [3]. - Shareholders are encouraged to register for the class action by January 12, 2026, to be eligible for potential recovery [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [4]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflated stock prices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Skye Bioscience, Inc. regarding a class action lawsuit due to allegations of misleading statements related to the company's lead product candidate, nimacimab [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from November 4, 2024, to October 3, 2025 [1]. - Allegations include that the effectiveness of nimacimab was overstated, leading to inflated clinical, regulatory, and commercial prospects [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by January 16, 2026, to potentially become lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [2]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Primo Brands Corporation regarding a class action lawsuit due to alleged false statements and poor merger integration with BlueTriton Brands, which has led to supply disruptions and negative financial impacts [1]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from June 17, 2024, to November 6, 2025 [1]. - Allegations include that the defendants concealed issues related to the merger integration, specifically technology and service problems, and falsely assured investors of a "flawless" execution [1]. - Major supply disruptions have been reported, which are expected to negatively affect customers and the financial results of Primo Brands [1]. Group 2: Shareholder Actions and Deadlines - Shareholders are encouraged to register for the class action by January 12, 2026, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies engage in responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of DexCom, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its glucose monitoring products, the G6 and G7, which could pose health risks to users [1]. Group 1: Allegations - The complaint alleges that DexCom made unauthorized design changes to the G6 and G7 glucose monitoring products, which rendered them less reliable than previous versions [1]. - It is claimed that these changes presented a material health risk to users who depend on these devices for accurate glucose readings [1]. - The lawsuit asserts that the enhancements to the G7, including its reliability, accuracy, and functionality, were overstated by the defendants [1]. - The defendants allegedly downplayed the severity of the issues and health risks associated with the altered G7 devices [1]. - The allegations suggest that DexCom faced increased regulatory scrutiny and potential legal, reputational, and financial harm due to these issues [1]. - As a result, the public statements made by the defendants were deemed materially false and misleading throughout the relevant period [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as January 8, 2024, to September 17, 2025, and shareholders are encouraged to register for participation [1][2]. - The deadline for shareholders to seek lead plaintiff status is December 26, 2025, and there is no cost or obligation to participate in the case [2]. - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's progress [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and engage in good corporate citizenship [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Perrigo Company plc regarding a class action lawsuit alleging that the company made materially false and misleading statements about its infant formula business, which was acquired from Nestlé, leading to overstated financial results [1]. Group 1: Allegations - The complaint alleges that the infant formula business suffered from significant underinvestment in maintenance, operational improvements, and repairs [1] - Perrigo needed to make substantial capital and operational expenditures beyond the company's stated cost estimates to remediate the infant formula business [1] - There were significant manufacturing deficiencies in the facility for the company's infant formula business [1] - As a result of these issues, the company's financial results, including earnings and cash flow, were overstated [1] - Defendants' positive statements about the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1] Group 2: Class Action Details - The class period for the lawsuit is from February 27, 2023, to November 4, 2025 [1] - Shareholders are encouraged to register for the class action by January 16, 2026, to potentially be appointed as lead plaintiff [2] - Once registered, shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case [2]

NEW YORK, Dec. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). Shareholders who purchased shares of TLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/telix-pharmaceuticals-ltd-loss-submission-form/?id=180979&from=4 CLASS PERIO ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Perrigo Company plc regarding a class action lawsuit alleging that the company made materially false and misleading statements about its infant formula business and its financial results during the specified class period [1]. Group 1: Allegations - The complaint alleges that the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs [1]. - Perrigo needed to make substantial capital and operational expenditures beyond the company's stated cost estimates to remediate the infant formula business [1]. - There were significant manufacturing deficiencies in the facility for the company's infant formula business [1]. - As a result of the aforementioned issues, the company's financial results, including earnings and cash flow, were overstated [1]. - The defendants' positive statements about the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - The class period for the lawsuit is from February 27, 2023, to November 4, 2025 [1]. - Shareholders are encouraged to register for the class action by January 16, 2026, to potentially be appointed as lead plaintiff [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the lifecycle of the case [2].

Core Viewpoint - The Gross Law Firm is notifying shareholders of DeFi Technologies (NASDAQ: DEFT) about a class action lawsuit due to alleged misleading statements and omissions regarding the company's financial performance and competitive position during a specified class period [1][3]. Group 1: Allegations - The complaint alleges that DeFi Technologies faced delays in executing its DeFi arbitrage strategy, which was a key revenue driver for the company [3]. - It is claimed that DeFi Technologies understated the competition it faced from other digital asset treasury companies, impacting its ability to execute its DeFi arbitrage strategy [3]. - The company is unlikely to meet its previously issued revenue guidance for the fiscal year 2025 due to the aforementioned issues [3]. - Defendants allegedly downplayed the true scope and severity of the negative impacts on DeFi Technologies' business and financial results [3]. - Public statements made by the defendants were materially false and misleading throughout the class period [3]. Group 2: Class Action Details - The class period for the lawsuit is from May 12, 2025, to November 14, 2025 [3]. - Shareholders are encouraged to register for the class action by January 30, 2026, to potentially be appointed as lead plaintiffs [4]. - There is no cost or obligation for shareholders to participate in the case, and they will receive updates through a portfolio monitoring software [4]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of StubHub Holdings, Inc. regarding a class action lawsuit related to misleading statements made by the company during its initial public offering in September 2025 [1][4]. Group 1: Class Action Details - The lawsuit is on behalf of individuals and entities that purchased StubHub common stock during the specified class period linked to the company's IPO [3]. - Shareholders are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment, although this is not necessary to participate in any recovery [1][4]. Group 2: Allegations - The complaint alleges that the company made materially false and misleading statements, failing to disclose significant changes in payment timing to vendors [4]. - These changes adversely affected the company's free cash flow, leading to misleading reports regarding free cash flow for the trailing 12 months [4]. - As a result, the positive statements made by the defendants about the company's business and prospects were deemed materially misleading and lacked a reasonable basis [4]. Group 3: Next Steps for Shareholders - The deadline for shareholders to register for the class action is January 23, 2026, and they will be enrolled in a portfolio monitoring system for updates on the case [5]. - There is no cost or obligation for shareholders to participate in the case [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Avantor, Inc. regarding a class action lawsuit due to allegations of misleading statements and failure to disclose critical information about the company's competitive position and operational challenges [1][3]. Group 1: Allegations - The complaint alleges that during the class period from March 5, 2024, to October 28, 2025, Avantor's competitive positioning was weaker than publicly represented by the defendants [3]. - It is claimed that Avantor was negatively affected by increased competition, which was not disclosed to shareholders [3]. - As a result, the representations made by the defendants regarding the company's business, operations, and prospects were materially false and misleading or lacked a reasonable basis [3]. Group 2: Class Action Details - Shareholders who purchased shares of AVTR during the specified class period are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment, although this is not required for recovery [1][4]. - The deadline for shareholders to register for the class action and seek lead plaintiff status is December 29, 2025 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. Group 3: Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit, fraud, and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and engage in good corporate citizenship [5].